Cabaletta Bio Inc (CABA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access CABA Annual Balance Sheets →
The data below summarizes Cabaletta Bio Inc's balance sheet position from Jun 30 2025 to Jun 30 2026, enabling a period-by-period comparison of financial strength.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent225.10
Short-term Investments, Total0.00
Cash & Short-term Investments225.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current5.93
Total Current Assets231.03
Equipment/Property/Plant Net1.48
Other Assets, Noncurrent24.22
Operating Lease Right Of Use Asset2.45
Total Assets256.73
Liabilities
Accounts Payable, Current AC5.81
Accrued Liabilities, Current5.66
Other Liabilities, Current28.44
Total Current Liabilities39.91
Total Long-term Debt0.00
Other liabilities, Noncurrent6.23
FinanceLeaseLiabilityNoncurrent3.33
Accrued Liabilities And Other Liabilities Current12.01
Total Liabilities46.14
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock822.08
Retained Earnings / Accumulated Deficit-611.49
Other Equity0.00
Common Stockholder's Equity210.59
Total Stockholder's Equity210.59
Liabilities & Stockholder's Equity256.73
4 historic quarters locked

Sign in to unlock the full Cabaletta Bio Inc balance sheet history.

About Cabaletta Bio Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001759138-26-000039

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.